Drugs / PLX73086
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02673736 | Feb 2016 → Jan 2018 | cancer, synovitis, tenosynovial giant cell tumor | Plexxikon | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PLX73086 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02673736 ↗ |